title: Treatment of necrobiosis lipoidica with etanercept and adalimumab.
authors.affiliation: Baylor College of Medicine, Houston, Texas, USA.
authors.forename: Kevin S
authors.initials: KS
authors.lastname: Zhang
authors.forename: Long T
authors.initials: LT
authors.lastname: Quan
authors.forename: Sylvia
authors.initials: S
authors.lastname: Hsu
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D009335:Necrobiosis Lipoidica / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068879:Adalimumab; D000068800:Etanercept